Literature DB >> 21800355

IRon Overload screeNing tool (IRON): development of a tool to guide screening in primary care.

Arch G Mainous1, Vanessa A Diaz, Charles J Everett, Michele E Knoll, Mary M Hulihan, Althea M Grant, Christine E McLaren, Gordon D McLaren.   

Abstract

Iron overload is associated with significant morbidity and mortality yet is easily treated. The objective of this study was to create a tool that could be easily adapted to clinical practice that indicates the likelihood of a patient having undetected iron overload. We used the National Health and Nutrition Examination Survey (NHANES) 1999-2002 for US adults aged 20 years and older to build a model (unweighted n=8,779). We chose potential variables for inclusion that could be gathered by self-report or measured without laboratory data and were suggested by past literature on hemochromatosis and iron overload. We computed logistic regressions to create the scores by initially evaluating the variables' relationship with elevated ferritin and elevated transferrin saturation and then using odds ratios to correspond to scores. The resulting score on the IRon Overload ScreeNing Tool (IRON) was then validated with data on 13,844 adults in the NHANES III, 1988-94. Predictors in the final tool were age, gender, previous diagnoses of liver condition, osteoporosis or thyroid disease. The IRON score yielded an area under the curve (AUC) in the NHANES 1999-02 of 0.720 and an AUC of 0.685 in the NHANES III validation sample. The IRON score is a tool to assist in identification of patients with iron overload that has several qualities that make it attractive for use in clinical practice with an undifferentiated patient population including brevity, easily collected information and predictive ability comparable to other tools that help in directing screening.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800355      PMCID: PMC3779368          DOI: 10.1002/ajh.22082

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  22 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

Authors:  K K Steinberg; M E Cogswell; J C Chang; S P Caudill; G M McQuillan; B A Bowman; L M Grummer-Strawn; E J Sampson; M J Khoury; M L Gallagher
Journal:  JAMA       Date:  2001-05-02       Impact factor: 56.272

Review 3.  Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening.

Authors:  M E Cogswell; S M McDonnell; M J Khoury; A L Franks; W Burke; G Brittenham
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

4.  Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Mark Aronson; Nick Fitterman; Vincenza Snow; Kevin B Weiss; Douglas K Owens
Journal:  Ann Intern Med       Date:  2005-10-04       Impact factor: 25.391

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 6.  Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Betsy A Garlitz; Emily L Harris; Tracy L Beil; Paula R Smith
Journal:  Ann Intern Med       Date:  2006-08-01       Impact factor: 25.391

Review 7.  Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

Authors:  D L Witte; W H Crosby; C Q Edwards; V F Fairbanks; F A Mitros
Journal:  Clin Chim Acta       Date:  1996-02-28       Impact factor: 3.786

8.  Hemochromatosis and iron-overload screening in a racially diverse population.

Authors:  Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

9.  Prediction of coronary heart disease in middle-aged adults with diabetes.

Authors:  Aaron R Folsom; Lloyd E Chambless; Bruce B Duncan; Adam C Gilbert; James S Pankow
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

10.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.

Authors:  S A Grover; I Lowensteyn; K L Esrey; Y Steinert; L Joseph; M Abrahamowicz
Journal:  BMJ       Date:  1995-04-15
View more
  2 in total

1.  HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.

Authors:  Paul C Adams; Christine E McLaren; Mark Speechley; Gordon D McLaren; James C Barton; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

2.  An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.

Authors:  Patricia Martins Conde; Thomas Sauter; Thanh-Phuong Nguyen
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.